HLD200 methylphenidate hydrochloride capsules
HLD200-112
Phase 3 small_molecule terminated
Quick answer
HLD200 methylphenidate hydrochloride capsules for Attention Deficit Hyperactivity Disorder is a Phase 3 program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- Attention Deficit Hyperactivity Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated